Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2022 Jul 05

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Letter to the Editor   Free accessfree

Minerva Medica 2022 Jul 05

DOI: 10.23736/S0026-4806.22.08236-2

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Third-line Pyrotinib, Trastuzumab (Zercepac®) and Vinorelbine for brain metastases of HER2-positive advanced breast cancer patient

Huan WANG, Bin SHAO, Lijun DI

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China


PDF


top of page